152
Participants
Start Date
July 31, 2019
Primary Completion Date
August 6, 2020
Study Completion Date
July 28, 2021
Spesolimab
Subcutaneous injections of Spesolimab starting at week 16, for a total treatment time until week 52.
Placebo
Subcutaneous injections of placebo matching Spesolimab from week 0 to 16.
Spesolimab
Subcutaneous injections of Spesolimab in a low dose scheme for a total treatment time of 52 weeks.
Spesolimab
Subcutaneous injections of Spesolimab in a medium-low dose scheme for a total treatment time of 52 weeks.
Spesolimab
Subcutaneous injections of Spesolimab in a medium-high dose scheme for a total treatment time of 52 weeks.
Spesolimab
Subcutaneous injections of Spesolimab in a high dose scheme for a total treatment time of 52 weeks.
Brussels - UNIV Saint-Luc, Brussels
Westmead Hospital, Westmead
Paratus Clinical Research Woden, Phillip
UZ Leuven, Leuven
Royal Melbourne Hospital, Parkville
Skin Health Institute Inc, Carlton
CRU Hungary Ltd, Private Practice, Miskolc, Miskolc
Veracity Clinical Research, Wooloongabba
University of Pecs, Pécs
Veszprem County Csolnoky Ferenc Hospital, Veszprém
Markusovszky University Teaching Hospital, Szombathely
National Taiwan University Hospital, Taipei
Charité - Universitätsmedizin Berlin, Berlin
Sanatorium Prof. Arenebergera, Prague
Seoul National University Bundang Hospital, Seongnam
University of Pittsburgh Medical Center, Pittsburgh
Paddington Testing Co., Inc., Philadelphia
Gachon University Gil Medical Center, Incheon
Virginia Clinical Research, Inc., Norfolk
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel
Advanced Medical Research PC, Sandy Springs
HOP Larrey, Toulouse
Total Skin and Beauty Dermatology Center, PC, Birmingham
Universitätsklinikum Frankfurt, Frankfurt am Main
Washington University School of Medicine, St Louis
University of Missouri Health System, Columbia
Epiphany Dermatology of Kansas, LLC, Overland Park
Skin Specialists, P.C., Omaha
Universitätsklinikum Heidelberg, Heidelberg
HOP Saint-Louis, Paris
Menter Dermatology Research Institute, Dallas
University of Utah Health, Murray
Wallace Medical Group, Beverly Hills
Universitätsklinikum Erlangen, Erlangen
Therapeutics Clinical Research, San Diego
Dermatovenereological Dispensary #10, St. Petersburg, Saint Petersburg
"LLC Medical Center Azbuka Zdorovia", Kazan'
SBHI Chelyabinsk Reg.Clin.Derma.Dispen., Chelyabinsk
The Psoriasis Treatment Center of Central New Jersey, East Windsor
CARe Clinic, Red Deer
Dr. Irina Turchin PC Inc., Fredericton
SimcoDerm Medical and Surgical Dermatology Centre, Barrie
The Guenther Dermatology Research Centre, London
York Dermatology Clinic and Research Centre, Richmond Hill
K. Papp Clinical Research Inc., Waterloo
Innovaderm Research Inc., Montreal
CCBR Czech a.s., Pardubice
CCBR Czech Prague s.r.o., Prague
HOP l'Archet, Nice
Nagoya City University Hospital, Aichi, Nagoya
Fujita Health University Hospital, Aichi, Toyoake
Tokyo Dental College Ichikawa General Hospital, Chiba, Ichikawa
Ehime University Hospital, Ehime, Toon
Fukuoka University Hospital, Fukuoka, Fukuoka
Gifu University Hospital, Gifu, Gifu
Asahikawa Kosei General Hospital, Hokkaido, Asahikawa
Asahikawa Medical University Hospital, Hokkaido, Asahikawa
Takagi Dermatological Clinic, Hokkaido, Obihiro
Hosui General Medical Clinic, Hokkaido, Sapporo
Takamatsu Red Cross Hospital, Kagawa, Takamatsu
Sagamihara National Hospital, Kanagawa, Sagamihara
Kumamoto University Hospital, Kumamoto, Kumamoto
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Kyoto
Tohoku University Hospital, Miyagi, Sendai
Shinshu University Hospital, Nagano, Matsumoto
Okayama University Hospital, Okayama, Okayama
University of the Ryukyus Hospital, Okinawa, Nakagami-gun
Kindai University Hospital, Osaka, Osaka-sayama
Nakatsu Dermatology Clinic, Osaka, Osaka
Osaka City University Hospital, Osaka, Osaka
Osaka University Hospital, Osaka, Suita
Shiga University of Medical Science Hospital, Shiga, Otsu
Jichi Medical University Hospital, Tochigi, Shimotsuke
Teikyo University Hospital, Tokyo, Itabashi-ku
Nihon University Itabashi Hospital, Tokyo, Itabashi-ku
Tokyo Medical University Hospital, Tokyo, Shinjuku-ku
Seibo Hospital, Tokyo, Shinjuku
Shirasaki Dermatology and Neurology Clinic, Toyama, Takaoka
Wakayama Medical University Hospital, Wakayama, Wakayama
Amphia Ziekenhuis, Breda
Barbara Rewerska Diamond Clinic, Krakow, Krakow
Dermoklinika medical center, Lodz, Lodz
Independent Public Clin.Hosp.no1 Lublin, Lublin
Municipal Hospital Complex in Olsztyn, Olsztyn
Dermmedica Sp. z o.o., Wroclaw, Wroclaw
Seoul National University Hospital, Seoul
Royal Devon and Exeter Hospital, Exeter
Guy's Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY